• OPEN AN ACCOUNT
Indian Indices
Nifty
17,080.70 129.00
(0.76%)
Sensex
57,960.09 346.37
( 0.60%)
Bank Nifty
39,910.15 342.25
( 0.86%)
Nifty IT
28,011.30 308.55
( 1.11%)
Global Indices
Nasdaq
11,926.24 210.16
(1.79%)
Dow Jones
32,717.60 323.35
(1.00%)
Hang Seng
20,309.13 116.73
(0.58%)
Nikkei 225
27,782.93 -100.85
(-0.36%)
Forex
USD-INR
82.23 -0.09
(-0.10%)
EUR-INR
89.03 0.31
(0.35%)
GBP-INR
101.31 0.39
(0.38%)
JPY-INR
0.63 0.00
(0.20%)

EQUITY - MARKET SCREENER

Tinplate Company of India Ltd
Industry :  Mining / Minerals / Metals
BSE Code
ISIN Demat
Book Value()
504966
INE422C01014
112.1909334
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TINPLATE
16.06
3223.31
EPS(TTM)
Face Value()
Div & Yield %
19.17
10
1.3
 

sun pharmaceuticals industries ltd
Sun Pharmaceutical Industries acquires three brands from Aksigen
Jan 30,2023
Sun Pharmaceutical Industries announced that it has acquired three brands viz. Disperzyme® (Trypsin BP 96 mg, Bromelain 180 mg & Rutoside Trihydrate 200 mg), Disperzyme-CD® (Trypsin BP 48 mg, Bromelain 90 mg & Rutoside Trihydrate 100 mg) and Phlogam® (Trypsin BP 48 mg, Bromelain 90 mg & Rutoside Trihydrate 100 mg) from Aksigen Hospital Care (Aksigen), a Mumbai based research driven healthcare entity with more than two decades of experience in the healthcare field.

All the brands are approved by the Drugs Controller General of India (DCGI) for post-operative inflammation in patients undergoing minor surgery and dental procedures.